Eledon Pharmaceuticals, Inc. (ELDN)
3.41
-0.04
(-1.16%)
USD |
NASDAQ |
Aug 24, 16:00
3.40
-0.01
(-0.29%)
After-Hours: 05:08
Eledon Pharmaceuticals Market Cap : 275.84M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 275.84M |
| August 21, 2026 | 279.08M |
| August 20, 2026 | 284.74M |
| August 19, 2026 | 287.16M |
| August 18, 2026 | 292.83M |
| August 17, 2026 | 289.59M |
| August 14, 2026 | 286.36M |
| August 13, 2026 | 299.30M |
| August 12, 2026 | 304.96M |
| August 11, 2026 | 303.34M |
| August 10, 2026 | 279.13M |
| August 07, 2026 | 279.89M |
| August 06, 2026 | 262.45M |
| August 05, 2026 | 260.93M |
| August 04, 2026 | 264.72M |
| August 03, 2026 | 260.17M |
| July 31, 2026 | 256.38M |
| July 30, 2026 | 258.65M |
| July 29, 2026 | 251.07M |
| July 28, 2026 | 257.90M |
| July 27, 2026 | 270.79M |
| July 24, 2026 | 271.55M |
| July 23, 2026 | 283.69M |
| July 22, 2026 | 282.17M |
| July 21, 2026 | 299.61M |
| Date | Value |
|---|---|
| July 20, 2026 | 292.79M |
| July 17, 2026 | 308.72M |
| July 16, 2026 | 291.27M |
| July 15, 2026 | 304.92M |
| July 14, 2026 | 307.20M |
| July 13, 2026 | 292.79M |
| July 10, 2026 | 292.03M |
| July 09, 2026 | 313.27M |
| July 08, 2026 | 319.34M |
| July 07, 2026 | 298.10M |
| July 06, 2026 | 301.13M |
| July 02, 2026 | 299.61M |
| July 01, 2026 | 295.82M |
| June 30, 2026 | 298.86M |
| June 29, 2026 | 294.30M |
| June 26, 2026 | 286.72M |
| June 25, 2026 | 276.86M |
| June 24, 2026 | 300.37M |
| June 23, 2026 | 299.61M |
| June 22, 2026 | 289.00M |
| June 18, 2026 | 297.34M |
| June 17, 2026 | 280.65M |
| June 16, 2026 | 263.96M |
| June 15, 2026 | 260.17M |
| June 12, 2026 | 270.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 138.73B |
| Viking Therapeutics, Inc. | 3.876B |
| ACADIA Pharmaceuticals, Inc. | 5.104B |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
| Anika Therapeutics, Inc. | 285.59M |
Market Cap Related Metrics
| Price to Book Value | 8.355 |
| Price | 3.41 |
| Earnings Yield | -29.04% |